Status:
COMPLETED
Improved Quality of the Treatment and Increased Compliance in Asthmatics Through the Dialog Tool Soren - Between Patient and Caregiver
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
The purpose of the study is to assess if a dialog tool can improve compliance and asthma control in patients with asthma.
Eligibility Criteria
Inclusion
- Diagnosis of asthma \>/= 3 months,
- Prescribed daily use of inhaled glucocorticosteroid
Exclusion
- Asthma exacerbation within the last month
Key Trial Info
Start Date :
February 1 2006
Trial Type :
INTERVENTIONAL
End Date :
May 1 2007
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00272727
Start Date
February 1 2006
End Date
May 1 2007
Last Update
January 24 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Copenhagen, Denmark